We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

85 hedge funds and large institutions have $38.3M invested in Aravive, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 35 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $138K | Put options by funds: $101K

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

12% less capital invested

Capital invested by funds: $43.3M → $38.3M (-$4.98M)

20% less funds holding

Funds holding: 10685 (-21)

46% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 35

53% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 38

Holders
85
Holders Change
-21
Holders Change %
-19.81%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
18
Increased
19
Reduced
35
Closed
38
Calls
$138K
Puts
$101K
Net Calls
+$37K
Net Calls Change
-$1.77M

ARAV Hedge Fund Activity: Q4 2017 in Review

85 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q4 2017, worth a combined $38.3M — down 12% from $43.3M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ARAV and 18 opened new positions — a net loss of 20 holders — while 35 trimmed existing stakes and 19 added.

The largest buyer was Morgan Stanley, adding an estimated $2.08M. The largest seller was BlackRock, cutting an estimated $1.33M.

  • 85 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q4 2017, down from 106 in Q3 2017.
  • Funds reported $38.3M of Aravive, Inc. Common Stock stock for Q4 2017, down 12% quarter-over-quarter.
  • 18 funds opened new Aravive, Inc. Common Stock positions in Q4 2017 and 38 closed out, a net change of -20 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q4 2017 was Morgan Stanley, an estimated $2.08M added.
  • The largest Aravive, Inc. Common Stock seller in Q4 2017 was BlackRock, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2017.